Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
- 1 March 1994
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 51 (3), 199-214
- https://doi.org/10.1001/archpsyc.1994.03950030035004
Abstract
From JAMA Psychiatry — Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans — Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine ResponsesKeywords
This publication has 68 references indexed in Scilit:
- Studies of the role of the N-methyl-D-aspartate (NMDA) receptor in the hypothalamic control of prolactin secretionLife Sciences, 1992
- New wave of non-NMDA excitatory amino acid receptorsTrends in Pharmacological Sciences, 1991
- Classification and nomenclature of phencyclidine and sigma receptor sitesTrends in Neurosciences, 1987
- Excitotoxity and the NMDA receptorTrends in Neurosciences, 1987
- Effects of phencyclidine and ketamine on cardiovascular activity and temperature in the squirrel monkeyLife Sciences, 1987
- Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primatesJournal of Neural Transmission, 1987
- The Perceptual Alteration Scale: A Scale Measuring DissociationAmerican Journal of Clinical Hypnosis, 1986
- Stereospecific binding of 3H-phencyclidine in brain membranesLife Sciences, 1982
- On Frontal Lobe Functions: Psychiatric Patient ControlsCortex, 1974
- Circulatory Responses to Ketamine AnesthesiaAnesthesiology, 1972